These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 5628940)
21. Pharmacotherapy of gastrointestinal motor disorders. Schuurkes JA Rev Gastroenterol Mex; 1994; 59(2):165-70. PubMed ID: 7991970 [TBL] [Abstract][Full Text] [Related]
22. Clinical evaluation of anisotropine methyl bromide (valpin), an anticholinergic drug. Bachrach WH Am J Dig Dis; 1972 Jun; 17(6):505-12. PubMed ID: 4555460 [No Abstract] [Full Text] [Related]
23. Comparison of the pharmacological properties of deptropine, its methobromide--BS 7020a--and the 10,11-dehydro analogues. Timmerman H; Lavy UI; Mulder D Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):291-300. PubMed ID: 4394744 [No Abstract] [Full Text] [Related]
24. [Relations between anticholinergic effect and structure in alkane-alpha, omega-bis-ammonium compounds]. Gerlach FD; Lüllmann H; Ohnesorge FK; Wassermann O Arzneimittelforschung; 1970 Jun; 20(6):751-4. PubMed ID: 5468887 [No Abstract] [Full Text] [Related]
25. [Preliminary findings on the effects of a new antispastic drug (N-diethyl-methyl-ammonium ethyl bromide P-[2-(N-octyloxy)-benzoyl]-aminobenzoate) on the motor activity of the human gastric antrum]. Baldi F; Ferrarini F; Milazzo G; Miglioli M Clin Ter; 1980 Jul; 94(2):159-63. PubMed ID: 6969643 [No Abstract] [Full Text] [Related]
26. 5-hydroxy-3-piperidylidenemethane derivatives as spasmolytics. Kawazu M; Kanno T; Saito S; Tamaki H J Med Chem; 1972 Sep; 15(9):914-8. PubMed ID: 5051008 [No Abstract] [Full Text] [Related]
27. [Clinical experiences with a new selective antispastic derivative of anisotropine]. Vignola D; Galvani A Clin Ter; 1968 Oct; 47(2):175-85. PubMed ID: 5755355 [No Abstract] [Full Text] [Related]
28. [Value of a new combined antispasmodic-antalgic in current medical practice]. Galley P Therapeutique; 1969 Dec; 45(10):1021-4. PubMed ID: 5396160 [No Abstract] [Full Text] [Related]
29. [Clinical trial of a new analgesic and antispastic drug combination]. Mariani L; Pinto E Clin Ter; 1975 Feb; 72(3):255-73. PubMed ID: 48445 [No Abstract] [Full Text] [Related]
31. [Action of vedrenan in functional digestive disorders]. Mongin H; Pollini J Mars Med; 1968; 105(12):1003-7. PubMed ID: 5746248 [No Abstract] [Full Text] [Related]
32. [The treatment of intestinal motility disorders in infants and children]. Hübner B Dtsch Med J; 1969 Jun; 20(11):385-7. PubMed ID: 5800680 [No Abstract] [Full Text] [Related]
33. Central and peripheral anticholinergic potency of some drugs antagonistic to anticholinesterase poisoning. Madill HD; Stewart WC; Savoie ML Can J Physiol Pharmacol; 1968 Jul; 46(4):559-65. PubMed ID: 5668200 [No Abstract] [Full Text] [Related]
34. [Therapeutic experiences with a central sedative and peripheral analgesic-spasmolytic medication combination in gastrointestinal diseases]. Lampe W Med Welt; 1968 Jun; 23():1427-30. PubMed ID: 5718202 [No Abstract] [Full Text] [Related]
36. [Endoscopic observations in patients with gastroduodenopathies during treatment with a drug association with antivagal and tranquilizing action]. Mirelli E; Fichera G Minerva Med; 1967 Sep; 58(70):2967-81. PubMed ID: 4383245 [No Abstract] [Full Text] [Related]
37. [Chemical structure and cholinolytic activity of bis-quaternary ammonium derivatives of truxillic acid]. Samoĭlov DN Farmakol Toksikol; 1971; 34(4):413-20. PubMed ID: 4258600 [No Abstract] [Full Text] [Related]
38. [Effect of certain pharmacological agents on barium chloride-induced arrhythmia in rabbits]. L'vov MV Zh Eksp Klin Med; 1973; 13(6):24-8. PubMed ID: 4139845 [No Abstract] [Full Text] [Related]
39. [Ganglioblocking and muscarinolytic activity of a series of phosphinic acid derivatives]. Abduvakhabov AA; Godovikov NN; Gurdaliev KhKh; Kabachnik MI; Kardanov NA Dokl Akad Nauk SSSR; 1974 Mar; 216(2):444-7. PubMed ID: 4151641 [No Abstract] [Full Text] [Related]